4-Hydroxynonenal (4-HNE) is a major byproduct of lipid peroxidation, a process exacerbated by mitochondrial dysfunction and oxidative stress. Accumulation of 4-HNE protein adducts has been reported in several cardiovascular diseases, such as myocardial infarction, hypertension and heart failure in both rodents and humans. Therefore, identifying critical 4-HNE targets relevant to cardiac pathophysiology could help develop better therapies to treat heart failure.
Notícia
BioWorld
4-Hydroxynonenal inhibition of Dicer directly impairs miRNA biogenesis in heart failure (21 notícias)
Publicado em 24 de novembro de 2023
Essa notícia também repercutiu nos veículos:
Medical Xpress (Reino Unido)
New Atlas (Austrália)
Scienmag Science Magazine (Reino Unido)
MDLinx (EUA)
Mirage News (Austrália)
Tech Explorist (Índia)
Santé log (França)
Nuadox (Canadá)
DDW - Drug Discovery World (Reino Unido)
PressNews.org
Pharmacy Times (EUA)
cnBeta (China)
BNN - Breaking News Network (EUA)
Homebrew Energy
Nurse News
WinAlly (Turquia)
Nurse Times (Itália)
Focus.ua (Ucrânia)
Seha24 (Líbano)
PharmacyAngle (EUA)